Their mission is to address the behavioral, psychological, and emotional needs of individuals with disabilities using therapeutic approaches that assure continued participation in supported society.
Uncategorized
Thoughts of gratitude: The Dewey family is a catalyst of support for the Waisman Center
Individuals with Down syndrome are at higher risk of developing Alzheimer’s disease, and it typically presents it at an earlier age than the general population. It is estimated that 90% of people with Down syndrome will have developed Alzheimer’s by age 65.
One mutation, many challenges: Unraveling the mystery behind fragile X syndrome
One mutation in a single gene, as straightforward as it may sound, can cause a broad range of symptoms and severity among those who carry it. This is the case for fragile X syndrome (FXS), the most common hereditary form of intellectual disability.
Waisman’s new Spanish radio show helps connect with Madison’s Hispanic community
For the next hour, Rivera-Bonet and Montoto spoke with Qiang Chang, PhD, director of the Waisman Center, and Paola Perez, MSSW, social worker and Waisman Center clinics operations manager, about the Waisman Center and its broad range of research, resources, and services for individuals with intellectual and developmental disabilities and their families.
Thank You 2022 Waisman Whirl Participants, Volunteers and Sponsors
The Waisman Center, Friends of the Waisman Center, and the Waisman Whirl planning committee would like to thank the hundreds of individuals and organizations who help make the 2022 Whirl a success! Highlights of the …
New $11 million award to study intellectual disability in Down syndrome
Waisman investigators Anita Bhattacharyya, PhD, an assistant professor of cell and regenerative biology and Su-Chun Zhang, MD, PhD, professor of neuroscience and neurology at the School of Medicine and Public Health at UW-Madison, were awarded …
Manufacturing pharmaceuticals for the fight against COVID-19
Waisman Biomafacturing (WB) is at the forefront of the fight against COVID-19 with one vaccine and two therapeutic products in development. “Waisman Biomanufacturing’s mission is to advance novel vaccines and therapeutics into early human clinical …
Increasing accessibility: telehealth brings unexpected benefits
The COVID-19 pandemic pivoted many daily life activities, such as work and school, to a home base. Healthcare was no exception. In March, the Waisman Center Clinics transitioned all of its services to telehealth appointments …